Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.360
-0.090 (-3.67%)
At close: Oct 28, 2025, 4:00 PM EDT
2.400
+0.040 (1.69%)
Pre-market: Oct 29, 2025, 7:03 AM EDT

Alzamend Neuro Statistics

Total Valuation

Alzamend Neuro has a market cap or net worth of $8.97 million. The enterprise value is $3.35 million.

Market Cap8.97M
Enterprise Value 3.35M

Important Dates

The next estimated earnings date is Thursday, December 11, 2025, after market close.

Earnings Date Dec 11, 2025
Ex-Dividend Date n/a

Share Statistics

Alzamend Neuro has 3.80 million shares outstanding. The number of shares has increased by 1,121.34% in one year.

Current Share Class 3.80M
Shares Outstanding 3.80M
Shares Change (YoY) +1,121.34%
Shares Change (QoQ) +196.09%
Owned by Insiders (%) 0.16%
Owned by Institutions (%) 0.96%
Float 3.78M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.39
P/TBV Ratio 1.68
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.03

Current Ratio 6.03
Quick Ratio 5.72
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -732.97

Financial Efficiency

Return on equity (ROE) is -302.25% and return on invested capital (ROIC) is -188.65%.

Return on Equity (ROE) -302.25%
Return on Assets (ROA) -97.46%
Return on Invested Capital (ROIC) -188.65%
Return on Capital Employed (ROCE) -116.68%
Revenue Per Employee n/a
Profits Per Employee -$976,194
Employee Count7
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -83.71% in the last 52 weeks. The beta is -0.28, so Alzamend Neuro's price volatility has been lower than the market average.

Beta (5Y) -0.28
52-Week Price Change -83.71%
50-Day Moving Average 2.39
200-Day Moving Average 5.03
Relative Strength Index (RSI) 48.76
Average Volume (20 Days) 132,309

Short Selling Information

The latest short interest is 104,714, so 2.75% of the outstanding shares have been sold short.

Short Interest 104,714
Short Previous Month 209,633
Short % of Shares Out 2.75%
Short % of Float 2.77%
Short Ratio (days to cover) 0.61

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -6.23M
Pretax Income -6.24M
Net Income -6.83M
EBITDA -6.17M
EBIT -6.23M
Earnings Per Share (EPS) -$7.15
Full Income Statement

Balance Sheet

The company has $5.62 million in cash and n/a in debt, giving a net cash position of $5.62 million or $1.48 per share.

Cash & Cash Equivalents 5.62M
Total Debt n/a
Net Cash 5.62M
Net Cash Per Share $1.48
Equity (Book Value) 5.34M
Book Value Per Share 1.70
Working Capital 4.95M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.88 million and capital expenditures -$210,000, giving a free cash flow of -$8.09 million.

Operating Cash Flow -7.88M
Capital Expenditures -210,000
Free Cash Flow -8.09M
FCF Per Share -$2.13
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Alzamend Neuro does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,121.34%
Shareholder Yield -1,121.34%
Earnings Yield -76.16%
FCF Yield -90.12%

Analyst Forecast

The average price target for Alzamend Neuro is $42.00, which is 1,679.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target $42.00
Price Target Difference 1,679.66%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on May 12, 2025. It was a reverse split with a ratio of 1:9.

Last Split Date May 12, 2025
Split Type Reverse
Split Ratio 1:9

Scores

Altman Z-Score n/a
Piotroski F-Score 1